Olema Pharmaceuticals OLMA
NASDAQ OLMA
$8.27 -0.37 (-4.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Olema Pharmaceuticals (OLMA) Return on Equity [ROE] (2020 - 2026)

Updated

Olema Pharmaceuticals' Return on Equity [ROE] was -44.82% in Q2 2026, down 5.76 percentage points from -39.07% a year earlier and down 6.17 percentage points from the prior quarter.

Analysis

Olema Pharmaceuticals (OLMA) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Olema Pharmaceuticals came in at -36.61%, up 2.48 percentage points from FY2024.

  • Return on Equity [ROE] has now increased for three consecutive years, though with a five-year change of -23.11 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -39.10% in FY2024 (+3.72 pp), -42.81% in FY2023 (+0.65 pp), -43.46% in FY2022 (-20.64 pp) and -22.82% in FY2021 (-9.31 pp).
  • Quarterly Return on Equity [ROE] has moved between -59.07% (Q1 2023) and -19.36% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Equity [ROE] was higher in four of the last eight quarters, with an average year-over-year change of -0.30 percentage points.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2024 (a gain of 18.54 percentage points); the worst was Q1 2023 (a drop of 30.42 percentage points).
  • Per Business Quant data, OLMA's Return on Equity [ROE] in the three quarters before Q2 2026 was -38.65% (Q1 2026), -41.34% (Q4 2025) and -45.92% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Olema Pharmaceuticals 755.59 Mn 755.59 Mn - -44.82%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -44.82%
Mar 31, 2026 -38.65%
Dec 31, 2025 -41.34%
Sep 30, 2025 -45.92%
Jun 30, 2025 -39.07%
Mar 31, 2025 -32.54%
Dec 31, 2024 -42.63%
Sep 30, 2024 -57.72%
Jun 30, 2024 -47.34%
Mar 31, 2024 -40.52%
Dec 31, 2023 -36.53%
Sep 30, 2023 -43.97%
Jun 30, 2023 -57.76%
Mar 31, 2023 -59.07%
Dec 31, 2022 -50.46%
Sep 30, 2022 -44.13%
Jun 30, 2022 -37.98%
Mar 31, 2022 -28.65%
Dec 31, 2021 -24.27%
Sep 30, 2021 -19.36%
API Access

Olema Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OLMA&period=max&api_key=YOUR_API_KEY